Description
Recombinant monoclonal antibody to CD62L. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma LAM1-116. This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2c format, for improved compatibility with existing reagents, assays and techniques.
Target
CD62L
Target Alias Names
SELL, L-selectin, LAM-1, LECAM1, Leukocyte surface antigen Leu-8, Leukocyte adhesion molecule 1, Lymph node homing receptor, CD62 antigen-like family member L, Leukocyte-endothelial cell adhesion molecule 1
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression